The results of the validation of the expression of highly upregulated genes SCM3 and CYP1B1 showed increasing mRNA levels of both SCM3 and CYP1B1 following ALS treatment (Figure 4C,D). This evidence concerns the gene CYP1B1 and amyotrophic lateral sclerosis.